Navigation Links
Marken Launches New Global Regulatory Consultation Services
Date:7/5/2012

RESEARCH TRIANGLE PARK, N.C., July 5, 2012 /PRNewswire/ -- Marken announced today the launch of the 'Marken Consultation Services'.  The new service provides global customs and agency regulation expertise for the pharmaceutical industry. 

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO)

Import and export requirements are increasingly more complicated with ever-changing industry guidance and governmental regulations. Marken has been able to overcome these regulatory challenges for their customers, which has contributed to its reputation for quality service. Marken keeps up to date with these changing regulations and provides solutions when necessary in order to keep shipments on time and on spec.  Marken experts include licensed customs brokers, import specialists, and life science experts, totaling more than 100 years of combined trade and regulatory compliance experience.

 "Navigating US customs and government agencies for shipping drugs, biologics, specimens and API's is a daunting and time-consuming task for the pharmaceutical industry, but this is what we do. We are offering this service to clients seeking advice before they start their planning.  We engage clients early in their process so we can lead them through the maze of regulations, thus allowing them to focus their energies on research and development," said Dan Bell, Director, Commercial Operations, & Regulatory Compliance for Marken.

Regulatory Solutions offered as part of the new service:                                             

  • Correctly classifying API to reduce customs & agency headaches and avoiding overpaying  duties
  • Ensuring compliance with trade laws and regulations for import & export
  • Improving customs handling times for clinical trials materials
  • Development of import strategies to significantly reduced import turn-around times
  • Provide training on the regulations for every region to expedite global shipments
  • Assistance with correct valuation for clinical trial material, including API, finished drug, ancillary/support equipment, and sample collection kits

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical industry, supporting over 49,000 investigators in more than 150 countries. Marken integrates Depot and Logistics services that extend the reach of clinical trials to the most remote geographies, leveraging decades of experience in logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Announces Global Advisory Board
2. Marken Opens Branch Office In Seoul, South Korea
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Ulthera Launches New Aesthetic Clinical Indication - Treatment of the Decolletage - in Asia
5. Bulgaria Launches Development of National Hepatitis Plan
6. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
7. Mylan Launches Thiamine Hydrochloride Injection
8. PeriGen, Inc. Launches Consumer Safety Campaign to Raise Awareness of Dangerous Birth Complication
9. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
10. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
11. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):